Back to search
FDAFDA · Food and drugs·Recall number Z-1369-2024

Cystatin C Calibrator - In vitro diagnostic (IVD) use in the calibration of the Randox Cystatin C assay on automated analysers Catalog Number: CVS 2699

Published April 3, 2024 · Recall initiated: February 14, 2024

Summary

FDA records medical device Class II recall Z-1369-2024, published April 3, 2024 and initiated February 14, 2024. Recalling firm: Randox Laboratories Ltd.; Status: Ongoing; Reported quantity: 666 units; Lot: GTIN: 05055273207439 (1) Batch 600957 Lot 1378CY - 1382CY (2) Batch 621809, 621815 Lot 1403CY - 1407CY (3) Batch 650533 Lot 1414CY - 1418CY. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cystatin C Calibrator Series CVS 2699, is running with a negative bias compared to other methods

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Randox Laboratories Ltd.
Distributor
US Nationwide distribution in the states of CA, IN.
Lot
GTIN: 05055273207439 (1) Batch 600957 Lot 1378CY - 1382CY (2) Batch 621809, 621815 Lot 1403CY - 1407CY (3) Batch 650533 Lot 1414CY - 1418CY
Risk classification
Class II
Area (FDA)
device
Country
Ireland

Related recalls

Questions about this recall

Was Cystatin C Calibrator - In vitro diagnostic (IVD) use in the calibration of the Randox Cystatin C assay on automated analysers Catalog Number: CVS 2699 recalled?

Yes. FDA published recall Z-1369-2024 on April 3, 2024. Reported hazard: Cystatin C Calibrator Series CVS 2699, is running with a negative bias compared to other methods

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail